Cargando…

Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study)

BACKGROUND: Modulation of endothelial function is a therapeutic option to reduce some of the significant complications of hypertension. However, the relationship between endothelial dysfunction reduced nitric oxide (NO) production, and the development of hypertension is not fully understood. To esta...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakabadze, Katevan, Megreladze, Irakli, Khvichia, Nino, Mitagvaria, Nodar, Kipiani, Nina, Dumbadze, Megi, Sanikidze, Tamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781263/
https://www.ncbi.nlm.nih.gov/pubmed/33447321
http://dx.doi.org/10.14740/cr1172
_version_ 1783631642815889408
author Kakabadze, Katevan
Megreladze, Irakli
Khvichia, Nino
Mitagvaria, Nodar
Kipiani, Nina
Dumbadze, Megi
Sanikidze, Tamar
author_facet Kakabadze, Katevan
Megreladze, Irakli
Khvichia, Nino
Mitagvaria, Nodar
Kipiani, Nina
Dumbadze, Megi
Sanikidze, Tamar
author_sort Kakabadze, Katevan
collection PubMed
description BACKGROUND: Modulation of endothelial function is a therapeutic option to reduce some of the significant complications of hypertension. However, the relationship between endothelial dysfunction reduced nitric oxide (NO) production, and the development of hypertension is not fully understood. To establish a potential pathogenetic link between impaired NO synthesis and hypertension, we investigated the results of competitive interaction of the substrate of NO synthase, L-arginine, and its analog, an non-selective inhibitor of NO synthase, N-nitro-methyl ether-L-arginine (L-NAME), in experimental rats. METHODS: Arterial hypertension was induced in male Wistar rats by intraperitoneal administration of L-NAME (Sigma-Aldrich) for 4 - 7 weeks. During the last 3 weeks, to a separate group of animals simultaneously with L-NAME, L-arginine (Sigma-Aldrich) was administered. In animals monitored for systolic and diastolic pressure, the level of NO in blood samples was determined spectrophotometrically using a Griess reagent. RESULTS: Administration of L-NAME for 4 - 7 weeks induced an irreversible decrease of NO content in blood, a reversible increase of systolic pressure (SP) and diastolic pressure (DP), and an irreversible increase in pulse pressure (PP). In rats against the background of 7 weeks of intraperitoneal administration of L-NAME, during the last 3 weeks, they were injected with L-arginine, the SP and DP indices returned to their initial values, PP decreased and the NO content in arterial blood increased. CONCLUSIONS: The results of the study indicate the presence of residual endothelial dysfunction (characterized by insufficient NO) after the correction of hypertension. Therefore, in developing the new therapeutic approaches for the treatment of hypertension, it is necessary to include drugs that, in addition to correcting blood pressure, will support normalization, and potentiation of endothelial function and endogenous NO synthesis.
format Online
Article
Text
id pubmed-7781263
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-77812632021-01-13 Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study) Kakabadze, Katevan Megreladze, Irakli Khvichia, Nino Mitagvaria, Nodar Kipiani, Nina Dumbadze, Megi Sanikidze, Tamar Cardiol Res Original Article BACKGROUND: Modulation of endothelial function is a therapeutic option to reduce some of the significant complications of hypertension. However, the relationship between endothelial dysfunction reduced nitric oxide (NO) production, and the development of hypertension is not fully understood. To establish a potential pathogenetic link between impaired NO synthesis and hypertension, we investigated the results of competitive interaction of the substrate of NO synthase, L-arginine, and its analog, an non-selective inhibitor of NO synthase, N-nitro-methyl ether-L-arginine (L-NAME), in experimental rats. METHODS: Arterial hypertension was induced in male Wistar rats by intraperitoneal administration of L-NAME (Sigma-Aldrich) for 4 - 7 weeks. During the last 3 weeks, to a separate group of animals simultaneously with L-NAME, L-arginine (Sigma-Aldrich) was administered. In animals monitored for systolic and diastolic pressure, the level of NO in blood samples was determined spectrophotometrically using a Griess reagent. RESULTS: Administration of L-NAME for 4 - 7 weeks induced an irreversible decrease of NO content in blood, a reversible increase of systolic pressure (SP) and diastolic pressure (DP), and an irreversible increase in pulse pressure (PP). In rats against the background of 7 weeks of intraperitoneal administration of L-NAME, during the last 3 weeks, they were injected with L-arginine, the SP and DP indices returned to their initial values, PP decreased and the NO content in arterial blood increased. CONCLUSIONS: The results of the study indicate the presence of residual endothelial dysfunction (characterized by insufficient NO) after the correction of hypertension. Therefore, in developing the new therapeutic approaches for the treatment of hypertension, it is necessary to include drugs that, in addition to correcting blood pressure, will support normalization, and potentiation of endothelial function and endogenous NO synthesis. Elmer Press 2021-02 2020-12-11 /pmc/articles/PMC7781263/ /pubmed/33447321 http://dx.doi.org/10.14740/cr1172 Text en Copyright 2021, Kakabadze et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kakabadze, Katevan
Megreladze, Irakli
Khvichia, Nino
Mitagvaria, Nodar
Kipiani, Nina
Dumbadze, Megi
Sanikidze, Tamar
Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study)
title Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study)
title_full Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study)
title_fullStr Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study)
title_full_unstemmed Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study)
title_short Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study)
title_sort some aspects of role of nitric oxide in the mechanisms of hypertension (experimental study)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781263/
https://www.ncbi.nlm.nih.gov/pubmed/33447321
http://dx.doi.org/10.14740/cr1172
work_keys_str_mv AT kakabadzekatevan someaspectsofroleofnitricoxideinthemechanismsofhypertensionexperimentalstudy
AT megreladzeirakli someaspectsofroleofnitricoxideinthemechanismsofhypertensionexperimentalstudy
AT khvichianino someaspectsofroleofnitricoxideinthemechanismsofhypertensionexperimentalstudy
AT mitagvarianodar someaspectsofroleofnitricoxideinthemechanismsofhypertensionexperimentalstudy
AT kipianinina someaspectsofroleofnitricoxideinthemechanismsofhypertensionexperimentalstudy
AT dumbadzemegi someaspectsofroleofnitricoxideinthemechanismsofhypertensionexperimentalstudy
AT sanikidzetamar someaspectsofroleofnitricoxideinthemechanismsofhypertensionexperimentalstudy